Grand Medical (Europe)
Galileilaan 15
2845 Niel
BE
Grand Medical (Europe)
Foundation date
16/04/2021
Sector
#PharmaSubsector
- #Therapeutics - Peptides
- #Therapeutics - Proteins
- #Other - Industrial Biotechnology
- #Pharma - Anti-infectives
- #Pharma - Gene therapy
- #Pharma - Generics
- #Pharma - Small molecule therapeutics
- #Pharma - Vaccines
Therapeutic areas
- #Cardiovascular
- #Conditions originating in the perinatal period
- #Digestive system
- #Neoplasms / cancer / oncology
- #Respiratory system
Grand Medical Europe (GME) is a newly established Belgian subsidiary of China Grand Pharmaceutical & Healthcare Holdings Limited (CGP). CGP ranks among China top Pharma and develops products and medical devices in respiratory, cardio/cerebrovascular, antiviral, anti-infection, oncology, ophthalmology, ENT, amino acids, CNS fields. GME is focusing on R&D collaboration with Belgian & European institutions and wishes to explore commercial cooperation with companies interested in the Chinese market.
Upcoming events
All events-
2809 '22
NLSDays 2022
Event by: SwedenBIO -
2405 '22
PrecisionMed Expo & Summit
Event by: Smart Planet Media International -
2405 '22
EMERGE GHI
Event by: Smart Planet Media International
Latest news
More news-
Latest field trials validate strength of Biotalys’ first biocontrol Evoca
Thursday May 19th 2022
Read more
-
Belgian biotech in European Top-3 despite turbulent times
Wednesday May 18th 2022
Read more
-
KU Leuven announces collaboration and license agreement with Gilead Sciences for the development of new antivirals against the respiratory syncytial virus
Wednesday May 18th 2022
Read more